Neurogene Inc.

8-K Entered a material agreement; Other events Jul 2, 2026 8-K Regulation FD disclosure; Other events Jun 29, 2026 8-K Regulation FD disclosure Jun 8, 2026 8-K Shareholder vote results Jun 4, 2026 8-K Results of operations (earnings release) May 12, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Director or officer change; Regulation FD disclosure Apr 20, 2026 10-K Fiscal year ended 2025-12-31 Mar 24, 2026 8-K Results of operations (earnings release) Mar 24, 2026 8-K Regulation FD disclosure Feb 26, 2026 8-K Regulation FD disclosure Jan 12, 2026 8-K Results of operations (earnings release) Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Regulation FD disclosure Nov 12, 2025 8-K Regulation FD disclosure Nov 6, 2025 8-K Regulation FD disclosure Oct 9, 2025 8-K Results of operations (earnings release) Aug 11, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Regulation FD disclosure Jun 30, 2025 8-K Director or officer change; Shareholder vote results Jun 12, 2025 8-K Other events Jun 9, 2025 8-K Results of operations (earnings release) May 9, 2025 10-Q Quarter ended 2025-03-31 May 9, 2025 8-K Entered a material agreement; Other events Apr 14, 2025 8-K Results of operations (earnings release) Mar 24, 2025 10-K Fiscal year ended 2024-12-31 Mar 24, 2025 8-K Regulation FD disclosure Jan 13, 2025 8-K Regulation FD disclosure Nov 21, 2024 10-Q Quarter ended 2024-09-30 Nov 18, 2024 8-K Results of operations (earnings release) Nov 18, 2024 8-K Regulation FD disclosure Nov 18, 2024 8-K Regulation FD disclosure Nov 12, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Nov 4, 2024 10-Q Quarter ended 2024-06-30 Aug 9, 2024 8-K Results of operations (earnings release) Aug 9, 2024 8-K Regulation FD disclosure Aug 7, 2024 8-K Regulation FD disclosure Jun 21, 2024 8-K Regulation FD disclosure Jun 18, 2024 8-K Shareholder vote results Jun 17, 2024 8-K Regulation FD disclosure Jun 3, 2024